Science Explorer Interactive view Map
Company · Alcobendas · Spain

Eli Lilly (Spain)

In research, Eli Lilly (Spain) stands highest in Health Sciences (#9,447 of 20,462 worldwide) and Medicine (#8,682 of 17,978 worldwide), over all time.

lilly.com/esROR OpenAlex
World rank, all time
#15,460
of 42,892
Rank in Spain
#389
of 927
Research works
353
▼ 28% vs 2013–17
Citations
9.1k
25.8 per fractional work
Top-10% rate
22.4%
record average 16.5%
Open access
37%
world 28%

What is Eli Lilly (Spain) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #9,447 of 20,462 22.9%150
MedicineField #8,682 of 17,978 20.5%138

Each strip is that field’s whole ranked pool, with the notch where Eli Lilly (Spain) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.16× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 1.48× its world share, 1 worksImmunology and Micro…Neuroscience: 0.29× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.27× its world share, 0 worksPharmacology, Toxico…Chemistry: 8.40× its world share, 5 worksChemistryComputer Science: 0.08× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.04× its world share, 0 worksEarth and Planetary …Energy: 0.47× its world share, 0 worksEnergyEngineering: 0.34× its world share, 2 worksEngineeringEnvironmental Science: 0.84× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.41× its world share, 1 worksMaterials ScienceHealth Professions: 1.51× its world share, 2 worksHealth ProfessionsMedicine: 2.74× its world share, 20 worksMedicineNursing: 0.19× its world share, 0 worksNursingBusiness, Management and Accounting: 0.21× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.08× its world share, 1 worksEconomics, Econometr…Psychology: 0.11× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 8.4×. Every wedge is a field page.

Who are the top researchers at Eli Lilly (Spain)?

Ranked on the composite score, Jesús Ezquerra, Concepción Pedregal and Tatiana Dilla lead among researchers whose main affiliation is Eli Lilly (Spain).

  1. 1 Jesús Ezquerra Spain · #570,497 worldwide 60 citations · 22 works
  2. 2 Concepción Pedregal Spain · #777,066 worldwide 64 citations · 18 works
  3. 3 Tatiana Dilla Spain · #1,152,056 worldwide 20 citations · 18 works
  4. 4 José Antonio Sacristán Spain · #1,589,256 worldwide 4 citations · 15 works
All ranked researchers at Eli Lilly (Spain)

Which keywords describe research at Eli Lilly (Spain)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Diabetes, Cardiovascular Disease, Breast Cancer, Type 2 Diabetes, Obesity and Medicinal Chemistry.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control4▲ 72×4 topics
  2. Insulin Therapy4▲ 84×3 topics
  3. Epidemiology4▲ 2.3×18 topics
  4. Diabetes3▲ 16×4 topics
  5. Cardiovascular Disease3▲ 7.0×12 topics
  6. Breast Cancer3▲ 28×3 topics
  7. Type 2 Diabetes2▲ 28×3 topics
  8. Obesity2▲ 8.2×8 topics
  9. Inflammation2▲ 2.7×10 topics
  10. Medicinal Chemistry2▲ 20×6 topics
  11. Metastatic Breast Cancer2▲ 91×2 topics
  12. CDK4/6 Inhibitors2▲ 198×1 topic
  13. Catalysis2▲ 7.5×5 topics
  14. Heart Failure2▲ 11×5 topics
  15. Palbociclib2▲ 198×1 topic
  16. Type 1 Diabetes2▲ 55×2 topics
  17. Clinical Guidelines2▲ 15×2 topics
  18. Cardiovascular Outcomes2▲ 76×1 topic
  19. Glucose Control2▲ 76×1 topic
  20. Cancer Therapy2▲ 6.9×6 topics
  21. Continuous Glucose Monitoring2▲ 82×1 topic
  22. Hypoglycemia2▲ 82×1 topic
  23. Cardiovascular Risk1▲ 12×3 topics
  24. Lifestyle Intervention1▲ 39×2 topics
  25. Single-Cell Analysis1▲ 57×2 topics
  26. Droplet Formation1▲ 83×1 topic
  27. Microfluidics1▲ 41×1 topic
  28. Primary Care1▲ 8.5×4 topics
  29. Solvent Selection1▲ 159×1 topic
  30. Sustainable Chemistry1▲ 159×1 topic
  31. Weight Loss1▲ 19×2 topics
  32. Autoantibodies1▲ 12×4 topics
  33. Clinical Trials1▲ 4.2×5 topics
  34. Diabetes Mellitus1▲ 15×3 topics
  35. Genetics1▲ 4.2×5 topics
  36. Metal-Catalyzed Reactions1▲ 48×2 topics
  37. Tumor Suppression1▲ 38×2 topics
  38. Health Outcomes1▲ 9.7×2 topics
  39. Partially Ordered Sets1▲ 264×1 topic
  40. Periodic Table1▲ 185×1 topic

Which research topics does Eli Lilly (Spain) publish most on?

By volume in 2022–2025: Advanced Breast Cancer Therapies, Diabetes Treatment and Management, Diabetes Management and Research and Innovative Microfluidic and Catalytic Techniques Innovation.

Advanced Breast Cancer T…2Advanced Breast Cancer Therapies: 2 fractional worksDiabetes Treatment and M…2Diabetes Treatment and Management: 2 fractional worksDiabetes Management and …2Diabetes Management and Research: 2 fractional worksInnovative Microfluidic …1Innovative Microfluidic and Catalytic Techniques Innovation: 1 fractional worksChemistry and Chemical Engineering: 1 fractional worksHistory and advancements in chemistry: 1 fractional worksHyperglycemia and glycem…1Hyperglycemia and glycemic control in critically ill and hospitalized patients: 1 fractional worksCancer-related Molecular Pathways: 1 fractional worksBariatric Surgery and Outcomes: 1 fractional worksCatalytic C–H Functionalization Methods: 1 fractional works
Pulmonary and Respiratory MedicineEndocrinology, Diabetes and MetabolismBiomedical EngineeringEnvironmental Chemistry4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  2. 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
  3. 3 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 2 works
  4. 4 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 1 works
  5. 5 Chemistry and Chemical Engineering Environmental Chemistry 1 works
  6. 6 History and advancements in chemistry Physical and Theoretical Chemistry 1 works
  7. 7 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 1 works
  8. 8 Cancer-related Molecular Pathways Oncology 1 works
  9. 9 Bariatric Surgery and Outcomes Surgery 1 works
  10. 10 Catalytic C–H Functionalization Methods Organic Chemistry 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.6%not open63.4%

World: 28% of research is openly available.

with international co-authors39.6%domestic only60.4%

World: 19% is written across borders.

How has Eli Lilly (Spain)'s research output changed?

Output in 2018–2022 was 28% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Alcobendas

All research institutions in Alcobendas

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.